At Insider Monkey we follow around 730 of the best-performing investors and even though many of them lost money in the last several months, the history teaches us that over the...
Keep Reading →
November 23 - Hedge Funds, News
Andreas Halvorsen's Viking Global is one of the rare hedge funds that has a monstrous amount of capital in its equity portfolio (over $26 billion), yet holds it all in a relatively...
Keep Reading →
November 18 - Hedge Fund Analysis, Hedge Funds, News, Tech
Sanford J. Colen founded Apex Capital, a San Francisco-based long/short equity hedge fund, in 1995. Prior to founding Apex Capital, Mr.
Keep Reading →
November 2 - Hedge Fund Analysis, Hedge Funds, News
Bernard Horn's Polaris Capital Management recently filed its 13F with the SEC for the reporting period of June 30.
Keep Reading →
August 10 - Hedge Fund Analysis, Hedge Funds, News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares reached as high as $83 per share in pre-market trading Monday, or over 18% higher than the stock’s closing price ...
Keep Reading →
July 27 - Hedge Funds, News
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois.
Keep Reading →
June 23 - Hedge Funds, News
Israel Englander of Millennium Management has increased his stake in NuVasive, Inc. (NASDAQ:NUVA) according to a recent 13G form filed with the SEC.
Keep Reading →
June 12 - Hedge Funds, News
According to a recent study by CIT, a reputable firm that is involved in financing and advisory services to the healthcare sector, healthcare executives seem rather optimistic...
Keep Reading →
May 26 - Hedge Funds, News
Israel Englander’s Millennium Management disclosed its holdings in US-traded equities for the reporting period of March 31 with the SEC.
Keep Reading →
May 21 - Hedge Funds, News
Billionaire Israel Englander of Millennium Management is taking the unprecedented step of launching a joint venture to keep the largest of his 170 trading teams in the fold.
Keep Reading →
April 28 - Hedge Funds, News
Krishen Sud’s Sivik Global Healthcare has filed its latest 13F with the SEC, disclosing the holdings in its equity portfolio as of March 31.
Keep Reading →
April 24 - Hedge Funds, News
Conan Laughlin’s North Tide Capital posted impressive first quarter returns of 10.1% from its 14 long positions in companies valued at $1 billion or greater.
Keep Reading →
April 17 - Hedge Funds, News
The six-year bull market has not been profitable for all investors, particularly for those who put an equal focus on shorting stocks as they do going long on them.
Keep Reading →
March 26 - Hedge Funds, News
Tracking the activity of billionaire hedge fund managers is a great way to identify profitable investments that will help you beat the market.
Keep Reading →
March 10 - Hedge Funds, News
Roberto Mignone's Bridger Management is a fund with around $2.0 billion in assets, one that is focused on healthcare stocks, which represent nearly one-half of the fund's equity...
Keep Reading →
March 3 - Hedge Funds, News
Billionaire George Soros’ Soros Fund Management has recently filed a Form 13F with the U.S.
Keep Reading →
February 19 - Hedge Funds, News
As the 13F season carries on, we continue to track the top hedge funds’ filings.
Keep Reading →
August 14 - Hedge Funds, News
North Tide Capital financial investment advisory firm headquartered in Boston, Massachusetts, founded and managed by Conan Laughlin. Before this, Mr.
Keep Reading →
June 4 - Hedge Funds, News
For the last several years, nobody has been more outspokenly bearish on Japan than Kyle Bass.
Keep Reading →
May 26 - Hedge Funds
Boston-based North Tide Capital was founded by Conan Laughlin in 2011. The fund focuses on the healthcare industry and has an estimated about $850 million in assets.
Keep Reading →
March 28 - Hedge Funds, News
Owl Creek Asset Management was founded in 2001 in New York by Jeffrey Altman, its current manager.
Keep Reading →
March 5 - Hedge Funds, News
Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is mostly the same.
Keep Reading →
February 24 - Hedge Funds, News
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Keep Reading →
February 18 - Hedge Funds, News
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Keep Reading →
February 7 - Hedge Funds, News
Of all of the many sound investing principles that legendary teacher and investor Ben Graham put forward, he believed that his concept of “margin of safety” was the most important...
Keep Reading →
September 19 - News
Big Pharma gets plenty of hype.
Keep Reading →
September 17 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
Keep Reading →
September 16 - News
There are plenty of biotech companies that put all of their eggs in one basket these days.
Keep Reading →
September 16 - News
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Keep Reading →
September 15 - News
A couple months may not seem like a long time, but when you're diagnosed with pancreatic cancer, the prospect of a few months makes a huge difference.
Keep Reading →
September 13 - Dividend Stocks, News
In a couple of years, Amgen, Inc. (NASDAQ:AMGN) will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe.
Keep Reading →
September 12 - News
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
Keep Reading →
September 12 - News
A couple of recent events got me thinking about price elasticity and how a savvy investor can capitalize on producers of inelastic products.
Keep Reading →
September 10 - News
Since the time covered in last week's update, Microsoft Corporation (NASDAQ:MSFT) lost more in market value for the real-money Inflation-Protected Income Growth portfolio ...
Keep Reading →
September 10 - News
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
Keep Reading →
September 5 - News
This past week has been fairly brutal to stocks as the situation in Syria deteriorated and American saber-rattling suggested that a military intervention may be right around the...
Keep Reading →
September 4 - News
Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products.
Keep Reading →
August 30 - News
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
Keep Reading →
August 27 - News
After a second offer, Amgen, Inc. (NASDAQ:AMGN) and Onyx Pharmaceuticals, Inc.
Keep Reading →
August 27 - News
Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends.
Keep Reading →
August 27 - Dividend Stocks, News
The wild swings in the market continued this past week, aided and abetted by both Goldman Sachs' trading glitch and the unexpected mid-session Nasdaq shutdown.
Keep Reading →
August 27 - News
Judging by the numbers, Galena Biopharma Inc (NASDAQ:GALE) isn't exactly a stock many would call great.
Keep Reading →
August 26 - News
A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals, Inc.
Keep Reading →
August 26 - News
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Keep Reading →
August 26 - News
Breast cancer claims more than 40,000 lives in the United States annually and is one of the leading causes of death for females globally.
Keep Reading →
August 23 - News
Like most pharma companies, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)'s stock price generally trades akin to the actions of a roller coaster.
Keep Reading →
August 22 - News
Bernard Horn, the manager of Polaris Capital Management, is a former employee of MDT Advisers.
Keep Reading →
August 19 - Hedge Funds
It's a disease that doesn't often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are focusing their efforts on to make a quality...
Keep Reading →
August 19 - News
Sometimes the market drops, as do even the greatest companies within it.
Keep Reading →
August 13 - News
Pharmaceutical companies are always looking for competitive advantages.
Keep Reading →
August 13 - News
